Diagnostic accuracy of urinary PlGF levels for preeclampsia in pregnancy: Systematic review and meta-analysis of case-control studies
Bliyeva R. Gaiday A. Bermagambetova S. Sachanova S. Karimsakova B. Tussupkaliyev A.
24 April 2025Mattioli 1885
Acta Biomedica
2025#96Issue 2
Background and aim: Despite growing interest in placental growth factor (PlGF) as a promising biomarker for preeclampsia, a comprehensive synthesis of urinary PlGF levels in this condition remains lacking. This systematic review and meta-analysis aim to quantify mean urinary PlGF levels (pg/mL) in women with preeclampsia compared to healthy controls, with and without creatinine adjustment. Methods: A systematic search of five databases was conducted by two independent researchers using the following keywords: “urine” AND “PlGF” OR “placental growth factor” AND “preeclampsia” OR “hypertensive disorders of pregnancy” OR “gestational hypertension,” according to the standard guidelines. Studies were included if they provided the mean and standard deviation of urinary PlGF levels among pregnant women with preeclampsia and healthy controls, with or without creatinine adjustment. Results: Seven articles were included. Five studies, encompassing seven groups, reported the mean urinary PlGF levels without creatinine adjustment. Using a random-effects model, the pooled mean PlGF level across these groups was 101.41 pg/mL (95% CI, 53.66–149.15) among healthy controls, compared with 32.24 pg/mL (95% CI, 21.48–43.02) in patients with preeclampsia. In three studies comprising five groups, the mean urinary PlGF levels were adjusted for creatinine. The pooled mean PlGF level for these groups, was 303.53 pg/mL (95% CI, 186.49–420.56) among healthy controls, versus 40.31 pg/mL (95% CI, 20.32–60.29) in patients with preeclampsia. Conclusions: Our findings demonstrate significantly reduced urinary PlGF levels in preeclampsia regardless of creatinine adjustment, supporting its potential as a non-invasive diagnostic biomarker. Further research should establish standardized measurement protocols and clinical thresholds for implementation. (www.actabiomedica.it).
biomarker validation , case-control studies , diagnostic biomarkers , meta-analysis , placental growth factor , placental proteins , preeclampsia , pregnancy , pregnancy complications , systematic review , urinary biomarkers
Text of the article Перейти на текст статьи
Department of Obstetrics and Gynecology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Hygienic Disciplines with Professional Diseases, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Scientific and Practical Center, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of General Medical Practice #1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Obstetrics and Gynecology
Department of Hygienic Disciplines with Professional Diseases
Scientific and Practical Center
Department of General Medical Practice #1
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026